Cell Therapy Manufacturing Market Size Worth USD 18.89 Billion by 2034 Driven by Rising Prevalence of Chronic Diseases

According to Precedence Research, the global cell therapy manufacturing market size is estimated to grow from USD 5.55 billion in 2025 to nearly USD 18.89 billion by 2034, representing a healthy CAGR of 14.61% from 2025 to 2034, driven by rising chronic disease cases and demand for personalized medicine.

Ottawa, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The global cell therapy manufacturing market is expected to hit a value milestone of USD 5.55 billion in 2025, demonstrating a remarkable 14.61% compound annual growth rate (CAGR) from 2025 to 2034. It is expected to increase from USD 6.38 billion in 2026 to USD 18.89 billion by 2034.

The Full Study is Readily Available | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/4283

Cell Therapy Manufacturing Market Key Takeaways

The global cell therapy manufacturing market was calculated at USD 4,830 million in 2024.
It is anticipated to touch USD 18,890 million by 2034.
The market is expected to expand at a double-digit CAGR of 14.61% from 2025 to 2034.
North America led the market with a major revenue share of 44% in 2024.
Asia Pacific is expected to witness the fastest growth during the forecast period.
By therapy type, the autologous cell therapy segment has held the biggest revenue share of 59% in 2024.
By therapy type, the allogenic cell therapy segment is projected to be the fastest-growing segment over the forecast period.
By technology type, the somatic cell technology segment held the largest share of the market in 2024.
By technology type, the 3D technology segment is expected to grow at the fastest rate during the projected period.
By source, the IPSC (induced pluripotent stem cell) segment dominated the market in 2024.
By source, the bone marrow segment is the second largest segment in the global market.
By application, the oncology segment has contributed the largest revenue share of 35% in 2024.
By application, the neurological segment is projected to show the fastest growth during the forecast period.
By end user, pharmaceutical and biotechnology companies held the dominant position in the cell therapy manufacturing market in 2024.
By end user, academic and research institutes are expected to be the fastest-growing segment in the market going forward.

Global Cell Therapy Manufacturing Market Size by Technology Type 2022 to 2024 (USD Million)

By Technology Type	2022	2023	2024
Somatic Cell Technology	823.2	925.9	1,045.3
Cell Immortalization Technology	461.2	515.2	577.6
Viral Vector Technology	736.8	844.3	971.5
Genome Editing Technology	692.2	786.1	896.3
Cell Plasticity Technology	418.3	461.8	511.4
3D Technology	623.6	730.3	858.1

Global Cell Therapy Manufacturing Market Size by Source 2022 to 2024 (USD Million)

Source	2022	2023	2024
IPSC’s (Induced pluripotent stem cell)	1,092.5	1,268.1	1,478.9
Bone marrow	801.3	914.6	1,048.3
Umbilical cord	648.2	723.2	809.6
Adipose tissue	721.2	812.6	919.0
Neural stem	492.3	545.1	604.5

Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/4283

Cell Therapy Manufacturing Market Overview

Cell therapy manufacturing is a complex process performed in controlled environments to treat various diseases. The multi-step process involves steps like cell sourcing, isolation & purification, cell modification, cell expansion, formulation, quality control, storage & distribution.

The manufacturing process can be allogenic or autologous. Cell therapy manufacturing offers benefits like treatment for complex diseases, fewer side effects, personalised medicine, and faster healing. Factors like advancements in biotechnology, supportive regulatory frameworks, increasing demand for personalised medicines, and growing prevalence of chronic diseases increase the adoption of cell therapy manufacturing.

Therapy & Technology-based Trends in Cell Therapy Manufacturing Market:

Autologous cell therapies (using the patient’s own cells) dominate the market due to lower risk of immune rejection.
Allogeneic therapies (using donor cells) are the fastest-growing segment because of their scalability and cost efficiency.
Somatic cell technology remains the most widely used for manufacturing.
3D technology is the fastest-growing, enabling personalized treatment and enhanced cell expansion through bioprinting and scaffold-based platforms.

➤ Get the Full Report @ https://www.precedenceresearch.com/cell-therapy-manufacturing-market

Top Procedures for Cell Therapy Manufacturing:

Process	Description
Cell Collection	The process of collecting living cells from allogenic or autologous methods for therapy. Collection Methods:- Blood Draws, Apheresis, and Tissue Biopsies
Cell Isolation & Purification	The process of separating cells from tissues using methods like bead technology and density gradient separation.
Cell Expansion	The process involves culturing cells using specialized culture systems like culture bags, bioreactors, and well plates in a controlled environment.
Genetic Modification	The process of altering DNA through techniques like viral vectors.
Formulation	The process of the development of final products and combining processed cells with excipients.
Quality Control & Testing	The step for ensuring the therapeutic product is safe and meets rigorous quality standards.
Cryopreservation	The process of preserving cells using controlled-rate freezers.
Shipping	The safe transportation of therapeutic products to the distribution centers, hospitals, and clinics.

Market Opportunity: Growing Prevalence of Chronic Disease Unlocks Market Opportunity

The increasing population and growing prevalence of chronic diseases like neurological disorders, cancer, and autoimmune disorders increase demand for cell therapy. The need for innovative and advanced therapies for chronic conditions increases the adoption of cell therapy. The strong focus on personalised therapy and a large patient pool with chronic conditions increases the demand for cell therapy.

The strong focus on treating chronic conditions increases demand for cell therapy. The increasing demand for targeted treatments and the high incidence of cancer increase the adoption of CAR-T cell therapies. The growing prevalence of chronic disease creates an opportunity for the cell therapy manufacturing market.

Limitations and Challenges: High Manufacturing Cost Limits Expansion of the Market

Despite several benefits of cell therapy manufacturing in various diseases, the high manufacturing cost restricts the market growth. Factors like stricter quality control, complex processes, specialized facilities, and skilled labor are responsible for high manufacturing costs. The complex, multi-step processes like cell expansion, cell collection, and genetic engineering increase the manufacturing cost.

The rigorous analytical testing and quality control increase the cost. The need for specialized equipment and skilled labor, like QA experts, researchers, & technicians, increases the manufacturing cost. The high-cost materials and need for advanced facilities & equipment increase the manufacturing cost. The high manufacturing cost hampers the growth of the cell therapy manufacturing market.

Report Scope of Cell Therapy Manufacturing Market

Report Coverage	Details
Market Size in 2024	USD 4.83 Billion
Market Size in 2025	USD 5.55 Billion
Market Size by 2034	USD 18.89 Billion
CAGR (2025 to 2034)	14.61%
Leading Region in 2024	North America
Fastest Growing Region	Asia Pacific
Base Year	2024
Forecast Period	2025 to 2034
Segments Covered	Therapy Type, Technology Type, Source, Application, and Region
Regions Covered	North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Key Players Covered	Merck KGaA, Thermo Fisher Scientific, Catalent, Inc, Bio-Techne, Cytiva, Lonza, The Discovery Labs, Novartis AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc.

➡️ Become a valued research partner with us ☎ https://www.precedenceresearch.com/schedule-meeting

Global Cell Therapy Market – The Foundation for Manufacturing Growth

Globally, the cell therapy market size reached USD 7.43 billion in 2025 and is projected to grow from to USD 9.13 billion in 2024 to USD 47.72 billion by 2034. This strong industry growth directly fuels demand for advanced cell therapy manufacturing capabilities. The North America cell therapy market size was valued at USD 3.56 billion in 2024 and is expanding at a CAGR of 23.07% during the forecast period.

Cell Therapy Market Key Takeaways

North America dominated the global cell therapy market with the largest market share of 59% in 2024.
Asia Pacific is expected to expand at a solid CAGR during the forecast period.
By therapy type, the autologous therapies segment contributed the highest market share of 92% in 2024.
By therapy type, the allogenic therapies segment is projected to grow at a solid CAGR during the forecast period.
By user type, the research use segment led the global market in 2024.
By user type, the clinical use segment is expected to grow at a notable CAGR during the forecast period.

The Complete Study is Immediately Accessible | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/1700

Cell Therapy Manufacturing Market Regional Analysis:

How Big is the U.S. Cell Therapy Manufacturing Market?

The U.S. cell therapy manufacturing market size was valued at USD 1.49 billion in 2024 and is projected to surpass nearly USD 5.87 billion by 2034, growing at a solid CAGR of 14.70% from 2025 to 2034.

Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.

Try Before You Buy – Get the Sample Report@ https://www.precedenceresearch.com/sample/4283

North America dominated the cell therapy manufacturing market in 2024. The ongoing research on gene therapy and the increasing development of advanced therapies increase the adoption of cell therapy manufacturing. The stricter regulatory framework and well-established healthcare system increase the demand for cell therapy manufacturing.

The growing diseases like neurological conditions, chronic illnesses, and cardiovascular diseases increase the adoption of cell therapy manufacturing. The strong presence of the biopharmaceutical industry and CDMOs drives the overall growth of the market.

Asia Pacific is experiencing the fastest growth in the market during the forecast period. The growing government investment in cell therapy and technological advancements in stem cell research help the market growth.

The growing prevalence of metabolic disorders, cancers, and autoimmune disorders increases the adoption of cell therapy manufacturing. The increasing patient population and favorable regulatory policies increase demand for cell therapy manufacturing. The expansion of clinical applications like CART therapy and a high number of gene therapies support the overall growth of the market.

Cell Therapy Manufacturing Market Segmentation Analysis

Therapy Type Analysis:

The autologous cell therapy segment dominated the cell therapy manufacturing market in 2024. The strong focus on personalised medicine and the growing prevalence of genetic disorders & cancers increase the adoption of autologous therapy. The increasing prevalence of multiple myeloma and growing innovations in the autologous stem cell therapies, helping the growth of the market. The growing expansion of clinical applications, like orthopedic treatments and autoimmune disorders, increases the adoption of autologous cell therapy, driving the overall growth of the market.

The allogenic cell therapy segment is experiencing the fastest growth in the market during the forecast period. The growing prevalence of chronic diseases like genetic disorders, cancer, and autoimmune diseases increases the adoption of allogenic cell therapy. The increasing age-related issues and advancements in allogenic cell therapy help the market growth. The growing demand for effective treatments and stringent regulatory frameworks like the EMA & FDA supports the overall growth of the market.

Technology Type Analysis

The somatic cell technology segment held the largest revenue share in the cell therapy manufacturing market in 2024. The strong regulatory approval and increasing clinical success increase the adoption of somatic cell technologies. The increasing prevalence of degenerative disorders, cancers, and autoimmune diseases increases the adoption of somatic cell technology. The focus on personalised treatments and increasing demand for tissue repair increases the adoption of somatic cell technology. The ongoing innovations in somatic cell technology drive the overall growth of the market.

The 3D technology segment is the fastest-growing in the market during the forecast period. The complexity in cellular interactions and improvements in drug development increase the adoption of 3D technology. The focus on improving drug efficacy and advancements in personalised medicine increases the demand for 3D technology. The focus on enhancing tissue engineering and strong support for cell proliferation increase the adoption of 3D technology, supporting the overall growth of the market.

Source Analysis

The IPSC segment dominated the cell therapy manufacturing market in 2024. The increasing need for the replacement of damaged organs and tissues increases the demand for IPSCs. The strong focus on personalised therapies and the increasing prevalence of chronic conditions increase the adoption of IPSC. The ongoing advancements in cell therapy and growing drug discovery increase the demand for IPSCs. The growing clinical trials and strong focus on regenerative medicine increase the adoption of IPSCs, driving the overall growth of the market.

The bone marrow segment is experience the fastest growth in the market during the forecast period. The growing prevalence of multiple myeloma, leukemia, and lymphoma increases the adoption of bone marrow. The strong focus on restoring normal blood cell production increases the demand for bone marrow. The growing conditions, like orthopedic conditions and autoimmune disorders, increase demand for bone marrow. The ongoing advancements in transplantation techniques and focus on personalised medicine increase the demand for bone marrow, supporting the overall growth of the market.

Application Analysis

The oncology segment held the largest revenue share in the cell therapy manufacturing market in 2024. The increasing prevalence of cancer and the development of CAR-T therapies increase demand for cell therapy manufacturing. The growth in conditions like leukemias and lymphomas increases the adoption of cell therapy. The strong supportive regulatory frameworks for novel oncology treatments and increasing investment in oncology cell therapies drive the overall growth of the market.

The neurological segment is the fastest-growing in the market during the forecast period. The growing conditions, like spinal cord injuries, Parkinson’s, and Alzheimer’s, increase demand for cell therapy. The strong focus on neural repair and replacement of damaged neurons increases the adoption of cell therapy. The growing clinical trials and increasing diagnosis of neurological conditions support the overall growth of the market.

Cell Therapy Manufacturing Market Leading Companies

Merck KGaA
Thermo Fisher Scientific
Catalent, Inc
Bio-Techne
Cytiva
Lonza
The Discovery Labs
Novartis AG
Bristol-Myers Squibb Company
Gilead Sciences, Inc.

Recent Developments:

In January 2025, CellFE launched its first-in-class T-Rest for CAR-T cell therapy manufacturing. It supports optimized gene editing workflows and helps to develop safer therapies. T-Rest reduces chromosomal abnormalities risks and provides researchers robust approach. (Source: https://www.biospace.com)
In December 2024, Thermo Fisher Scientific launched CTS Detachable Dynabeads CD8 and CD4 to enhance the production & development of cell therapy. It is effective for CAR-T cell therapy and enables efficient isolation of CD8+ & CD4+ T cells. It ensures high purity and lowers the cell stress. (Source: https://www.businesswire.com)
In October 2023, Bayer launched its first cell therapy manufacturing facility in California. The company invested $500m in the facility, and it includes cell therapy labs & cell culture technology. (Source: https://www.pharmaceutical-technology.com)

Segments Covered in the Report

By Therapy Type

Allogenic Cell Therapy
Autologous Cell Therapy

By Technology Type

Somatic Cell Technology
Cell Immortalization Technology
Viral Vector Technology
Genome Editing Technology
Cell Plasticity Technology
3D Technology

By Source

IPSC (Induced Pluripotent Stem Cell)
Bone Marrow
Umbilical Cord
Adipose Tissues
Neural Stem

By Application

Musculoskeletal
Cardiovascular
Gastrointestinal
Neurological
Oncology
Dermatology
Others

By Region

North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- Kuwait

Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.

Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/sample/4283

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344

Stay Ahead with Precedence Research Subscriptions

Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve.

Browse Our Subscription Plans@ https://www.precedenceresearch.com/get-a-subscription

About Us

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Web: https://www.precedenceresearch.com

Our Trusted Data Partners:

Get Recent News:

https://www.precedenceresearch.com/news

For the Latest Update Follow Us:

LinkedIn | Medium | Facebook | Twitter

✚ Related Topics You May Find Useful:

➡️ Cell and Gene Therapy Market: Explore how advanced therapies are transforming personalized medicine

➡️ U.S. Stem Cell Therapy Market: Track growth driven by regenerative medicine and chronic disease treatment

➡️ Automated and Closed Cell Therapy Market: See how automation is shaping scalable and efficient cell therapies

➡️ Allogeneic Cell Therapy Devices Market: Analyze innovations enabling off-the-shelf therapies

➡️ Stem Cell Manufacturing Market: Understand how production advances are supporting global demand

➡️ Primary Cell Culture Market: Discover the growing role of cell culture in biomedical research and drug discovery

➡️ Automated and Closed Cell Therapy Processing System Market: Learn how closed systems are enhancing safety and efficiency

➡️ Cell and Gene Therapy Infrastructure and Delivery Models Market: Explore how delivery frameworks are evolving to meet clinical demand

➡️ Stem Cells Market: Gain insights into therapeutic applications and regenerative medicine breakthroughs

➡️ Viral Vectors and Plasmid DNA Manufacturing Market: See how vectors power gene therapies and vaccine development

➡️ Viral Vectors-Based Gene Therapy for Non-Human Primates Market: Track preclinical advances driving translational research

➡️ Genome Editing Market: Explore CRISPR and emerging tools revolutionizing genetic research

➡️ Gene Editing Market: Understand commercial applications across healthcare and agriculture

➡️ Phase I-B Gene Editing Trials Market: Follow clinical trial progress and regulatory momentum

➡️ Gene Editing and mRNA Tool Kits Market: Discover the tools accelerating next-gen therapeutics

➡️ Cell and Gene Therapy CDMO Market: See how CDMOs are enabling clinical and commercial scale

➡️ Personalized Cell Therapy Market: Analyze demand for individualized treatment solutions

➡️ Cell and Gene Therapy Bioanalytical Testing Services Market: Learn how testing ensures safety, efficacy, and regulatory compliance

➡️ Cell and Gene Therapy Clinical Trials Market: Track how trials are expanding pipelines globally

➡️ T-Cell Therapy Market: Explore CAR-T and emerging therapies shaping oncology care

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.